ROCKVILLE, MD / ACCESS Newswire / June 16, 2025 / uBriGene Biosciences, a leading cell and gene therapy CDMO, is proud to ...

Accelerate@Babraham has unveiled its 2025 cohort, selecting five pioneering life science ventures from a competitive pool of ...

LAS VEGAS, NV / ACCESS Newswire / June 16, 2025 / Black Book Research, an independent healthcare technology research firm, announced today at AHIP 25 that Cohere Health has received the highest ...

Survey of Health Plan Leaders Recognizes Sagility for Automated Adjudication Accuracy, Claims Integrity, and Integrated Managed Member Support Services LAS VEGAS, NV / ACCESS Newswire / June 16, 2025 ...

Independent Survey Highlights Exceptional Performance in Fertility, Maternity, and Parental Health Solutions for Health Plans and Employer Wellness Programs LAS VEGAS, NV / ACCESS Newswire / June 16, ...

European Firms Rise Above Hundreds of HIT Exhibitors for Scalability, Regulatory Alignment, and High-Growth Market Readiness AMSTERDAM, NL / ACCESS Newswire / June 16, 2025 / Amid hundreds of health ...

HOUSTON, TEXAS / ACCESS Newswire / June 16, 2025 / Mann Eye Institute, a pioneering leader in vision correction for over three decades, today announced it is the first practice in Texas and third in ...

The global Nucleic Acid Isolation and Purification Market was valued at USD 902.9 million in 2020 and is projected to reach USD 1,174.1 million by 2025. From 2025 to 2035, the market is forecast to ...

NIPRO announces the launch of LiniXia, a strategic addition to its dialysis portfolio in next-generation reverse-osmosis (RO) water treatment. The new LiniXia RO green-generation water treatment ...

Therapeutics Market is projected to be valued at USD 962.4 million in 2025, reaching USD 1,523.4 million by 2035, with a compound annual growth rate (CAGR) of 4.7% during the forecast period. The ...

SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump ...

Partnership combines AbTherx's proprietary Atlas™ Long CDR3 Technology with GPCR Therapeutics' deep expertise in GPCR biology to discover and develop antibodies for novel targets MOUNTAIN VIEW, ...